Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy

J Kang, N Brajanovski, KT Chan, J Xuan… - Signal transduction and …, 2021 - nature.com
Ribosome biogenesis and protein synthesis are fundamental rate-limiting steps for cell
growth and proliferation. The ribosomal proteins (RPs), comprising the structural parts of the …

COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects

DM Smadja, SJ Mentzer, M Fontenay, MA Laffan… - Angiogenesis, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with …

Molecular map of chronic lymphocytic leukemia and its impact on outcome

BA Knisbacher, Z Lin, CK Hahn, F Nadeu… - Nature …, 2022 - nature.com
Recent advances in cancer characterization have consistently revealed marked
heterogeneity, impeding the completion of integrated molecular and clinical maps for each …

Genetics of MDS

S Ogawa - Blood, The Journal of the American Society of …, 2019 - ashpublications.org
Our knowledge about the genetics of myelodysplastic syndromes (MDS) and related
myeloid disorders has been dramatically improved during the past decade, in which …

Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS

JJ Trowbridge, DT Starczynowski - Journal of Experimental Medicine, 2021 - rupress.org
With a growing aged population, there is an imminent need to develop new therapeutic
strategies to ameliorate disorders of hematopoietic aging, including clonal hematopoiesis …

The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia

AS Sperling, CJ Gibson, BL Ebert - Nature Reviews Cancer, 2017 - nature.com
Myelodysplastic syndrome (MDS) is a clonal disease that arises from the expansion of
mutated haematopoietic stem cells. In a spectrum of myeloid disorders ranging from clonal …

The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes

DA Sallman, A List - Blood, The Journal of the American Society …, 2019 - ashpublications.org
In cancer biology, tumor-promoting inflammation and an inflammatory microenvironment
play a vital role in disease pathogenesis. In the past decade, aberrant innate immune …

The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype

AA Basiorka, KL McGraw, EA Eksioglu… - Blood, The Journal …, 2016 - ashpublications.org
Despite genetic heterogeneity, myelodysplastic syndromes (MDSs) share features of
cytological dysplasia and ineffective hematopoiesis. We report that a hallmark of MDSs is …

Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis

R Saiki, Y Momozawa, Y Nannya, MM Nakagawa… - Nature medicine, 2021 - nature.com
Clonal hematopoiesis (CH) in apparently healthy individuals is implicated in the
development of hematological malignancies (HM) and cardiovascular diseases. Previous …

[HTML][HTML] Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis

NB Leimkühler, HFE Gleitz, L Ronghui, IAM Snoeren… - Cell stem cell, 2021 - cell.com
Functional contributions of individual cellular components of the bone-marrow
microenvironment to myelofibrosis (MF) in patients with myeloproliferative neoplasms …